enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lenacapavir injection lowers HIV risk by 96% - AOL

   www.aol.com/lenacapavir-injection-lowers-hiv...

   One study revealed that injection of the medication lenacapavir every six months could greatly reduce the risk for HIV infection among at-risk individuals. Human immunodeficiency virus (HIV ...

3. Pre-exposure prophylaxis for HIV prevention - Wikipedia

   en.wikipedia.org/wiki/Pre-exposure_prophylaxis...

   Additional barriers transgender women face include concerns about side effects, hormone therapy, adherence, and interaction with healthcare workers. [96] Challenges encountered by people engaging in injection drug use include limited access to healthcare providers, expense of medication, and follow-up for HIV testing. [92]

4. Lenacapavir - Wikipedia

   en.wikipedia.org/wiki/Lenacapavir

   Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. [9] [10] It is taken by mouth or by subcutaneous injection.[9] [10]The most common side effects include reactions at the injection site and nausea.

5. Management of HIV/AIDS - Wikipedia

   en.wikipedia.org/wiki/Management_of_HIV/AIDS

   The combination of Rekambys and Vocabria injection is intended for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/ml) with their current ARV treatment, and when the virus has not developed resistance to certain class of anti-HIV medicines called non-nucleoside reverse transcriptase ...

6. Emtricitabine/tenofovir - Wikipedia

   en.wikipedia.org/wiki/Emtricitabine/tenofovir

   Injection of drugs in the last six months with sharing of equipment Serodiscordant heterosexual and homosexual partners, where one partner is HIV-positive and the other HIV-negative The consideration of utilizing emtricitabine/tenofovir as a reduction strategy involves discussion with a health professional who can help the patient navigate the ...

7. Gilead Unveils New Yearly HIV Injection To Offer Hope for ...

   www.aol.com/gilead-unveils-yearly-hiv-injection...

   At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a once-yearly injectable formulation for lenacapavir. The annual formulation is ...

8. Experts say a twice-yearly injection that offers 100% ... - AOL

   www.aol.com/lifestyle/experts-twice-yearly...

   There were no infections in the young women and girls that got the shots in a study of about 5,000 in South Africa and Uganda, researchers reported. Experts say a twice-yearly injection that ...

9. Cabotegravir - Wikipedia

   en.wikipedia.org/wiki/Cabotegravir

   Cabotegravir in combination with rilpivirine is indicated for the treatment of human immunodeficiency virus type-1 (HIV-1) in adults. [1] [7] The combination injection is intended for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/mL) with their current antiretroviral treatment, and when the virus has not developed resistance to ...